Holen Sie sich die Stockscreener-App
240.91
0.04%
0.42
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$240.49
Offen:
$239.02
24-Stunden-Volumen:
125.18K
Relative Volume:
0.06
Marktkapitalisierung:
$56.04B
Einnahmen:
$250.74B
Nettoeinkommen (Verlust:
$1.55B
KGV:
36.84
EPS:
6.5398
Netto-Cashflow:
$4.39B
1W Leistung:
-2.00%
1M Leistung:
+1.77%
6M Leistung:
+8.24%
1J Leistung:
+59.39%
1-Tages-Spanne:
$238.48
$241.64
1-Wochen-Bereich:
$238.48
$249.29
52-Wochen-Spanne:
$145.87
$258.30
Cardinal Health Inc Stock (CAH) Company Profile
Firmenname
Cardinal Health Inc
Sektor
Branche
Telefon
(614) 757-3033
Adresse
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
240.97 | 55.93B | 250.74B | 1.55B | 4.39B | 6.5398 |
MCK
Mckesson Corp
|
894.29 | 103.66B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
326.35 | 61.96B | 328.68B | 2.55B | 1.56B | 13.03 |
HSIC
Henry Schein Inc
|
88.49 | 9.90B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
0.8168 | 699.76M | 14.85M | -136.07M | 7.25M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Hochstufung | Argus | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Underweight |
| 2023-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Eingeleitet | Citigroup | Neutral |
| 2023-02-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-05-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-05-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-20 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-27 | Herabstufung | Argus | Buy → Hold |
| 2019-08-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-16 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Hochstufung | Argus | Hold → Buy |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-01-05 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Cardinal Health Inc Aktie (CAH) Neueste Nachrichten
Cardinal Health stock slips as analysts raise price targets and earnings outlook stays solid - AD HOC NEWS
Is Cardinal Health (CAH) Fully Valued As It Heads To The Wells Fargo Conference? - simplywall.st
Cardinal Health (CAH) Declines More Than Market: Some Information for Investors - Yahoo Finance
Cardinal Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Is Cardinal Health Building a New Tech-Enabled Healthcare Platform? - Yahoo Finance
Injectable Drug Delivery Market Forecast: USD 1,034.78 Billion by 2030 – MarketsandMarkets™ - Yahoo Finance
Cardinal Health stock gains on strong results and higher targets - AD HOC NEWS
Nagaraj Bhat Appointed Vice President/GM, Global Capability Center (GCC) Site Leader at DePuy Synthes - hrtoday.in
Cardinal Health stock holds firm as investors digest strong earnings and guidance - AD HOC NEWS
Is CAH Becoming the Backbone of US Healthcare Infrastructure? - Eastern Progress
Chicago Archbishop Cardinal Blase Cupich, 2 orders of Catholic nuns file lawsuit in effort to block IL medical aid-in-dying law - ABC7 Chicago
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - Currently.com
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Cencora (COR) Unveils Cell And Gene Therapy Enablement Service - simplywall.st
Cardinal Health leases Sacramento building for 100-job distribution center - bizjournals.com
Jim Cramer Makes Bold Cardinal Health (NYSE: CAH) Claim As Specialty Push Drives Earnings Growth - foreignpolicyjournal.com
Jim Cramer Notes Cardinal Health (CAH) is “Too Attractive to Ignore” - Yahoo Finance
Cardinal Health Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen - Yahoo Finance
Is Generics Still a Quiet Profit Engine for Cardinal Health? - Eastern Progress
Cardinal Health (CAH) Advances 2.57% to $245.49, Edging Toward Key Resistance at $257.76Risk Reward Setups - dars.gov.et
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health stock gains support from strong cash flow and dividend - AD HOC NEWS
Cardinal Health stock edges higher as investors eye FY 2027 guidance - AD HOC NEWS
Cardinal Health stock holds steady as consensus price targets point higher - AD HOC NEWS
Precision Trading with Cardinal Health Inc. (CAH) Risk Zones - Stock Traders Daily
Cardinal Health Inc. stock outperforms competitors despite losses on the day - MarketWatch
What Cardinal Health (CAH)'s Bigger Buyback, Dividend and New Credit Line Means For Shareholders - sahmcapital.com
Trade Alert: CEO & Director Of Cardinal Health Jason Hollar Has Sold Stock - simplywall.st
The CIO of Cardinal Health Parted With 11,650 Shares. Here's Whether It Matters for Long-Term Investors - Currently.com
Cardinal Health's CEO Moved 124,529 Shares in Two Days. Here's What Long-Term Investors Should Know - The Motley Fool
Cardinal Health CEO Sells $29 Million in Stock After Earnings Send Shares to Record - Barron's
Paralel Advisors LLC Invests $2.60 Million in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Updates Labeling for Leader Dry Eye Relief Eye Drops - geneonline.com
118,900 Shares in Cardinal Health, Inc. $CAH Bought by Ceredex Value Advisors LLC - MarketBeat
Cardinal Health stock holds firm after August 11 earnings - Ad-hoc-news.de
Great Lakes Advisors LLC Makes New $3.65 Million Investment in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health CEO Jason Hollar sells $29.4m in company stock - Investing.com South Africa
Cardinal Health Chief Accounting Officer Mary C. Scherer Sells 2,302 Shares in August 2026 - Kalkine Media
Cardinal Health (NYSE:CAH) CAO Sells 2,302 Shares of Stock - MarketBeat
Cardinal Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Cardinal Health stock holds close to record levels as insider sales and analyst targets frame the ne - Ad-hoc-news.de
Cardinal Health CEO Deborah Weitzman sells $1.73m in shares By Investing.com - Investing.com South Africa
Cardinal Health (CAH) CEO Jason Hollar Sells 124,529 Shares - GuruFocus
Cardinal Health PSS Segment CEO Deborah Weitzman Sells 7,354 Shares in August 2026 Transactions - Kalkine Media
Cardinal Health chief legal officer Jessica Mayer sells $6.95m in stock - Investing.com South Africa
Cardinal Health (NYSE:CAH) Insider Michelle Greene Sells 11,650 Shares - MarketBeat
Cardinal Health CFO Aaron Alt sells $9.9 million in shares By Investing.com - Investing.com South Africa
Cardinal Health CIO Greene sells $2.75m in stock By Investing.com - Investing.com South Africa
Cardinal Health CEO, GMPD segment Mason sells $8.27m shares - Investing.com
Cardinal Health CEO, GMPD segment Mason sells $8.27m shares By Investing.com - Investing.com India
Finanzdaten der Cardinal Health Inc-Aktie (CAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
2.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):